Identification of two specific transcriptomic clusters of COVID-19 acute respiratory distress syndrome patients with different immune profiles and different outcomes
Eur Respir J. 2023 Jan 27;61(1):2202008.
doi: 10.1183/13993003.02008-2022.
Print 2023 Jan.
Transcriptomic clustering of patients with ARDS due to COVID-19 identified different immune profiles and outcomes. This demonstrates heterogeneity among COVID-19 ARDS patients and may help to establish personalised therapies.https://bit.ly/3h61sCj